FR2758822B1 - Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus - Google Patents

Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus

Info

Publication number
FR2758822B1
FR2758822B1 FR9711166A FR9711166A FR2758822B1 FR 2758822 B1 FR2758822 B1 FR 2758822B1 FR 9711166 A FR9711166 A FR 9711166A FR 9711166 A FR9711166 A FR 9711166A FR 2758822 B1 FR2758822 B1 FR 2758822B1
Authority
FR
France
Prior art keywords
adenovirus
polypeptide
cellular receptor
receptor
cellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9711166A
Other languages
English (en)
Other versions
FR2758822A1 (fr
Inventor
Pierre Boulanger
Saw See Hong
Lucie Karayan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9701005A external-priority patent/FR2758821B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9711166A priority Critical patent/FR2758822B1/fr
Priority to PCT/FR1998/000184 priority patent/WO1998033929A2/fr
Priority to EP98905474A priority patent/EP0900280A2/fr
Priority to AU61046/98A priority patent/AU731911B2/en
Priority to CA002251036A priority patent/CA2251036A1/fr
Priority to JP10532596A priority patent/JP2000510708A/ja
Priority to US09/155,613 priority patent/US6420120B1/en
Publication of FR2758822A1 publication Critical patent/FR2758822A1/fr
Publication of FR2758822B1 publication Critical patent/FR2758822B1/fr
Application granted granted Critical
Priority to US10/156,820 priority patent/US20020150558A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10345—Special targeting system for viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
    • C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
    • C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
    • C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR9711166A 1997-01-30 1997-09-09 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus Expired - Fee Related FR2758822B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9711166A FR2758822B1 (fr) 1997-01-30 1997-09-09 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
CA002251036A CA2251036A1 (fr) 1997-01-30 1998-01-30 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
EP98905474A EP0900280A2 (fr) 1997-01-30 1998-01-30 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
AU61046/98A AU731911B2 (en) 1997-01-30 1998-01-30 Use of a polypeptide as cellular receptor for adenoviruses
PCT/FR1998/000184 WO1998033929A2 (fr) 1997-01-30 1998-01-30 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
JP10532596A JP2000510708A (ja) 1997-01-30 1998-01-30 アデノウイルスの細胞レセプターとしてのポリペプチドの使用
US09/155,613 US6420120B1 (en) 1997-01-30 1998-01-30 Use of a polypeptide as cell receptor for adenoviruses
US10/156,820 US20020150558A1 (en) 1997-01-30 2002-05-30 Use of a polypeptide as cellular receptor for adenoviruses

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701005A FR2758821B1 (fr) 1997-01-30 1997-01-30 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
FR9711166A FR2758822B1 (fr) 1997-01-30 1997-09-09 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus

Publications (2)

Publication Number Publication Date
FR2758822A1 FR2758822A1 (fr) 1998-07-31
FR2758822B1 true FR2758822B1 (fr) 1999-07-02

Family

ID=26233288

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9711166A Expired - Fee Related FR2758822B1 (fr) 1997-01-30 1997-09-09 Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus

Country Status (7)

Country Link
US (2) US6420120B1 (fr)
EP (1) EP0900280A2 (fr)
JP (1) JP2000510708A (fr)
AU (1) AU731911B2 (fr)
CA (1) CA2251036A1 (fr)
FR (1) FR2758822B1 (fr)
WO (1) WO1998033929A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4070499A (en) 1998-04-30 1999-11-16 Cornell Research Foundation Inc. Adenoviral vectors with tandem fiber proteins
US6455314B1 (en) 1998-09-11 2002-09-24 Genvec, Inc. Alternatively targeted adenovirus
IL133032A (en) * 1998-11-20 2007-06-03 Introgene Bv Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells
EP1020529B1 (fr) * 1998-11-20 2005-06-01 Crucell Holland B.V. Vecteurs d'apport de gènes munis d'un tropisme pour les cellules des muscles lisses et/ou les cellules endothéliales
EP1790736A3 (fr) 2000-10-06 2007-08-15 The Trustees Of Columbia University In The City Of New York Procédé massivement parallèle pour décoder l'adn et l'arn
US7026164B2 (en) * 2003-07-03 2006-04-11 Cell Genesys, Inc. Adenovirus packaging cell lines
EP1774575A2 (fr) * 2004-05-17 2007-04-18 Cambrios Technology Corp. Biofabrication de transistors y compris des transistors a effet de champ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639458A (en) * 1987-03-20 1997-06-17 Regents Of The University Of California Class I MHC modulation of surface receptor activity
US5385888A (en) 1987-03-20 1995-01-31 The Regents Of The University Of California Class I MHC modulation or surface receptor activity
US5719064A (en) * 1992-08-31 1998-02-17 Oklahoma Medical Research Foundation Peptide diagnostics and therapeutics for spondyloarthropathies
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
GB9514368D0 (en) * 1995-07-13 1995-09-13 Medical Res Council Improvements in or relating to binding assays

Also Published As

Publication number Publication date
WO1998033929A2 (fr) 1998-08-06
US20020150558A1 (en) 2002-10-17
US6420120B1 (en) 2002-07-16
CA2251036A1 (fr) 1998-08-06
EP0900280A2 (fr) 1999-03-10
FR2758822A1 (fr) 1998-07-31
AU731911B2 (en) 2001-04-05
AU6104698A (en) 1998-08-25
WO1998033929A3 (fr) 1998-11-19
JP2000510708A (ja) 2000-08-22

Similar Documents

Publication Publication Date Title
BR9510090A (pt) Utilização de um adenovírus recombinante
ATE315035T1 (de) Ccr-3-rezeptor-antagonisten
FR2765801B1 (fr) Utilisation de monoesters d'arbutine comme agent depigmentant
ATE449849T1 (de) Ob rezeptor-variante und liganden
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
DE69734833D1 (de) Vitronektin rezeptor antagonisten
EP0998285A4 (fr) ANTAGONISTES DU RECEPTEUR ADRENERGIQUE ALPHA 1a
GB9625843D0 (en) Phenyl spiroethercycloalkyl tachykinn receptor antagonists
DE69812602D1 (de) Antagonisten des vitronectin-rezeptors
ID24726A (id) Antagonis-antagonis reseptor trombin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
ID24162A (id) Antagonis-antagonis reseptor vitronektin
FR2758822B1 (fr) Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
EP1019052A4 (fr) ANTAGONISTES DU RECEPTEUR ADRENERGIQUE ALPHA 1a
FR2755165B1 (fr) Dispositif d'ancrage
EP1023068A4 (fr) ANTAGONISTES DES ADRENORECEPTEURS ALPHA 1a
FR2758821B1 (fr) Utilisation d'un polypeptide a titre de recepteur cellulaire des adenovirus
EP1014973A4 (fr) ANTAGONISTES DES ADRENORECEPTEURS ALPHA 1a
NO993172D0 (no) Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet
FR2756734B1 (fr) Utilisation de paracetamol comme agent depigmentant
PT977685E (pt) Ancoras maritimas
FR2762526B1 (fr) Malaxeur d'alginate ameliore
DE69838733D1 (de) Zementklinker enthaltender Zement
FR2764209B1 (fr) Preparation d'un catalyseur et utilisation de ce catalyseur pour la depollution d'un effluent photographique
HUP9904262A3 (en) Use of proteins as anti-retroviral agents

Legal Events

Date Code Title Description
ST Notification of lapse